Clinical trial
Colchicine as a Novel Anti-Inflammatory Strategy in Autoimmune and Subacute Thyroiditis: A Prospective Three-Arm Randomized Controlled Trial
NCT07571681 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Colchicine as a Novel Anti-Inflammatory Strategy in Autoimmune and Subacute Thyroiditis: A Prospective Three-Arm Randomized Controlled Trial
- Lead sponsor
- Mansoura University
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- June 15, 2026
- Completion date
- September 30, 2027
- Enrollment
- 300 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hashimoto thyroiditis, subacute thyroiditis, thyroiditis